The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
编者按:2024年,美国食品药品监督管理局(FDA)药物评估与研究中心(CDER)批准了50种新药(包括小分子药物、生物制剂和寡核苷酸治疗药物)。虽然这一数字略低于2023年的55种,但仍然是是过去30年中批准数量第二多的一年。同类首创药物(Firs ...
The rate of warnings initiated by the FDA continues to rise in the pharma and medical device industries. Knowing how to best ...